Augmented vagal heart rate modulation in active hypoestrogenic pre-menopausal women with functional hypothalamic amenorrhoea by Emma ODonnell (1384770) et al.
Augmented Vagal Heart Rate Modulation in Active Hypoestrogenic 
Premenopausal Women with Functional Hypothalamic Amenorrhea  
 
 
Emma O’Donnell1, Jack M Goodman1,2, Beverly L Morris3, John S Floras2,3,  
and Paula J Harvey4 
 
 
 
 
1Cardiovascular Research Laboratory, Department of Exercise Sciences, University of 
Toronto, Toronto, Ontario, Canada, and Department of Medicine, Division of Cardiology 
at the 2Mount Sinai Hospital, 3Toronto General Hospital, and 4Women’s College Hospital, 
University of Toronto, Ontario, Canada. 
 
 
 
 
 
 
Corresponding Author 
Dr Paula J Harvey, BMBS, PhD, FRACP 
Division of Cardiology, Women’s College Hospital,  
Department of Medicine, University of Toronto,  
76 Grenville Street 
Toronto, Ontario,    
M5S 1B3 
Canada 
Tel: 416-323-7722 
Fax: 416-323-6304 
Paula.harvey@wchospital.ca 
 
 
 
Running Title: Heart Rate Modulation in Amenorrheic Women 
 
Key words: autonomic nervous system; energy deficiency; estrogen; exercise; heart 
rate variability.  
 
Word Count: 4102 (excluding tables, figures, figure legends and references) 
 
 
 
 
2 
 
ABSTRACT 
Compared with eumenorrheic women, exercise-trained women with functional 
hypothalamic amenorrhea (ExFHA) exhibit low heart rates (HR) and absent reflex renin-
angiotensin-system activation and augmentation of their muscle sympathetic nerve 
response to orthostatic stress. To test the hypothesis that their autonomic HR 
modulation is altered concurrently, three age-matched (pooled mean, 24±1 years; 
mean±SEM) groups of women were studied: active with either FHA (ExFHA; n=11) or 
eumenorrheic cycles (ExOv; n=17), and sedentary with eumenorrheic cycles (SedOv; 
n=17). Blood pressure (BP), HR, and HR variability (HRV) in the frequency domain were 
determined during both supine rest and graded lower body negative pressure (LBNP; -
10, -20, and -40mmHg). Very low (VLF), low (LF) and high (HF) frequency power 
spectra (ms2) were determined and, due to skewness, log10 transformed.  LF/HF ratio 
and Total power (VLF+LF+HF) were calculated. At baseline, HR and systolic BP were 
lower (p<0.05), and HF and Total power higher (p<0.05) in ExFHA than eumenorrheic 
women.  In all groups, LBNP decreased (p<0.05) systolic BP, HF and Total power, and 
increased (p<0.05) HR, and LF/HF ratio.  However, HF and Total power remained higher 
(p<0.05), and HR, systolic BP and LF/HF ratio lower (p<0.05) in ExFHA than 
eumenorrheic women, in whom measures did not differ (p>0.05). At each stage, HR 
correlated inversely (p<0.05) with HF.  In conclusion, ExFHA women demonstrate 
augmented vagal yet unchanged sympathetic HR modulation, both at rest and during 
orthostatic stress.  Although the role of estrogen deficiency per se is unclear, these 
findings contrast with studies reporting decreased HRV in hypoestrogenic 
postmenopausal women.  
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INTRODUCTION 
Functional hypothalamic amenorrhea (FHA) is a reversible cause of premenopausal 
ovarian suppression.  FHA is characterized by chronically low levels of circulating 
estradiol that resemble those observed in postmenopausal women and men [1,2].  The 
prevalence of FHA is markedly higher in active (~1-44%) versus sedentary (~2-5%) 
women [3], and has been causally related to energy deficiency due to high energy 
expenditure (i.e., exercise) and insufficient caloric intake [4].  During simulated 
orthostatic stress, exercise trained women with FHA (ExFHA) demonstrate lower heart 
rate (HR) and systolic blood pressure, augmented reflex sympathetic outflow to muscle 
yet absent reflex increases in plasma renin and angiotensin II compared with their 
eumenorrheic counterpart [5].  These observations suggest that cardiac autonomic 
regulation may also be altered in ExFHA women.   
HR variability (HRV) provides both insight into cardiac vagal and sympathetic 
heart rate modulation and prognostic information [6].  Increased HRV is associated with 
decreased risk of cardiovascular events [6]. In contrast, low HRV attributed to elevated 
sympathetic modulation of HR predicts increased risk of cardiac arrhythmias post-
myocardial infarction [6] and a higher risk of fatal and non-fatal cardiovascular events 
even in apparently healthy individuals [7,8].  Estrogen deficiency in postmenopausal 
women is associated with diminished HRV as a consequence of increased sympathetic 
and/or decreased vagal tone [9,10].  Conversely, exercise trained hypoestrogenic 
postmenopausal women exhibit higher HRV and greater cardiac vagal tone compared to 
their sedentary counterpart [9,10].  The influence of estrogen deficiency on HRV in 
exercise-trained premenopausal women with FHA is unknown.    
The purpose of this study was to investigate the consequences of 
hypoestrogenemia in physically active premenopausal women with FHA for HR 
regulation.  Therefore, in estrogen deficient ExFHA women and estrogen-replete 
exercise-trained and sedentary eumenorrheic women, we compared HRV both at rest 
and during an orthostatic hypotensive challenge (lower body negative pressure, LBNP) 
to reflexively increase HR.  We anticipated, from the literature [11,12], that HR would be 
lower in ExFHA women compared with eumenorrheic women, both at rest and during 
LBNP, and hypothesized this would be due to greater parasympathetic modulation.  
 
 
METHODS 
Subjects: Volunteers were recruited by posters targeting both sedentary and physically 
active premenopausal women. Screening procedures included general questionnaires 
on exercise, eating behaviour, menstrual cycle, and medical health. Eligibility criteria for 
the study included: 1) age 18 to 35 yrs; 2) absence of chronic illness, including diabetes, 
hyperprolactinemia, poly-cystic ovarian syndrome, and thyroid disease; 3) stable 
menstrual status over the preceding 3 months (i.e., either absence of menses or 
menstrual cycles between 25-35 days); 4) not taking any mediations; 5) non-smoker; 6) 
not currently dieting and weight stable for the preceding 3 months; 7) no history or 
current clinical diagnosis of eating disorders; and 8) absence of hormonal therapy for at 
least 6 months. The study was carried out in accordance with the Declaration of Helsinki 
(2008) of the World Medical Association, and the study was approved by the local 
University and Hospital Research Ethics Boards.  All volunteers provided written 
informed consent. 
 
Experimental Design:  Volunteers were recruited consecutively over three years to 
participate in a larger cross-sectional study examining the cardiovascular consequences 
of estrogen deficiency in premenopausal women.  Fifty-seven women participated in the 
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larger study, which comprised three smaller studies. Participants enrolled in 1-3 of these 
smaller studies. In the current paper, subject characteristic data, and heart rate and 
blood pressure recorded at rest and during LBNP for ExOv and ExFHA groups include, 
in part, data from participants that have previously been reported by our group [5,11].  
The present study reports novel data on our primary outcome variable, HRV, which was 
assessed at rest and during LBNP in forty-one of the 57 women. 
 
Exercise and Menstrual Status Definitions:  Volunteers were grouped according to 
exercise status (exercising or sedentary) and menstrual/ovulatory status (eumenorrheic 
and ovulatory, or amenorrheic). To conform with previously published convention with 
respect to studies in such women, exercise status was defined as “sedentary” when 
purposeful exercise was < 2 hours per week and “exercising” when purposeful exercise 
was conducted > 2 hours per week [13]. Further, based on literature describing ‘average’ 
peak aerobic capacity between 38-42 in sedentary women [14] a cut’ off of ≤40 
ml/kg/min defined “sedentary” status and >40 ml/kg/min reflected “exercising” status.  
Eumenorrhea was defined as 10-13 menstrual cycles per year. Ovulation, confirmed 
during the menstrual cycle prior to testing, was detected using a urinary ovulation 
hormone kit (Clearblue Easy ovulation test, Unipath Diagnostics, Waltham, MA).  FHA in 
association with exercise training was defined as cessation of menses for 90 or more 
consecutive days [3].   
 
Study Groups: Three study groups were established: recreationally exercise trained 
women with FHA (ExFHA; n=12) or eumenorrheic ovulatory menstrual cycles (ExOv; 
n=14), and sedentary women with eumenorrheic ovulatory menstrual cycles (SedOv; 
n=15).  To examine the effects of estrogen deficiency in physically active women on 
HRV, values in amenorrheic physically active women with FHA were compared to those 
observed in eumenorrheic ovulatory estrogen-replete physically active women.  
Sedentary eumenorrheic ovulatory estrogen-replete physically active women were 
recruited as a ‘normal’ healthy reference group.    
 
Subject Preparation: All measures were obtained during the early follicular phase (low 
estrogen and progesterone phase; days 2-6) of the menstrual cycle in eumenorrheic 
subjects, and on a random day for amenorrheic women.  Thus, we were able to compare 
the cardiovascular effects of cyclically low estrogen (eumenorrheic women) versus 
chronically low estrogen (FHA women) levels.  All tests occurred in the morning between 
0930-1030 in a quiet ambient temperature room (22-24 ºC). Volunteers had fasted at 
least 2 hours and abstained from alcohol 12 hours, and caffeine and exercise for 24 
hours, prior to testing. 
 
Anthropometric Measures and Body Composition: Total body mass and height were 
determined using a physician’s balance scale (Detecto, Webb City, MO). Body 
composition was determined using dual-energy x-ray absorptiometry (DXA; Prodigy, 
General Electric Lunar Corporation, Madison, WI).  
 
Peak Aerobic Capacity: On a separate study day, peak aerobic capacity (VO2 peak) 
was measured using a metabolic cart during a progressive treadmill test to exhaustion 
(Moxus Modular VO2 System, Applied Electrochemistry Inc., Pittsburgh, PA).   
 
Blood Sampling:  Using standard venipuncture techniques, blood samples were 
collected at baseline for determination of serum 17 β-estradiol, progesterone, 
testosterone, and sex hormone binding globulin (SHBG).  On a separate day, 8-hour 
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fasted serum free triiodothyronine (T3) was also assessed to provide an estimate of 
energy status, with low T3 levels indicating low energy status (i.e., energy deficiency) 
[15].  Free androgen index ([total testosterone/SHBG]*100) was calculated to provide an 
estimate of androgenicity [16].  All assays were run by the Core Laboratory at the 
Toronto General Hospital.  
 
Blood Pressure and Heart Rate: Measurements of brachial systolic (SBP), diastolic 
(DBP), mean arterial BP (MAP) and HR were recorded from the left upper-arm using an 
automated device (Dinamap Pro 100, Critikon, USA).  Brachial BP and HR were 
assessed at one minute intervals at baseline (three consecutive stable measures) and 
every minute throughout each stage of LBNP.  The recordings acquired during the last 
four minutes of each LBNP stage were averaged to acquire a mean value for each 
LBNP stage.  Continuous recordings of HR and BP were also acquired using lead II of 
an electrocardiogram and a photoplethysmographic device on the index finger 
(Portapres Model-2, Finapres Medical Systems BV, USA), respectively.   
 
Heart Rate Variability:  Frequency domain analysis of HRV was performed as 
described previously [17]. In brief, 7-minute recordings of continuous HR intervals (R-R) 
were collected using lead II of an ECG during spontaneous breathing at baseline and 
during each stage of LBNP. The ECG signal was sampled at 1000Hz and was stored 
using LabView (National Instruments, Austin, TX) for off-line analysis.  Frequency 
domain analysis was performed using a nonparametric method of fast Fourier 
transformation (FFT).  Each 7-minute data set comprised 2,048 data points which were 
divided into seven segments, each containing 512 points, with one-half overlapping of 
each segment. The linear trend in the data was subtracted from the data set in each 
segment, and a Blackman-Harris window was applied to minimize spectral leakage.  The 
power spectrum was subsequently quantified into very low (VLF: 0.001–0.05 Hz), low 
(LF: 0.05 to 0.15 Hz) and high (HF: 0.15 to 0.5 Hz) frequencies.  Frequency domains 
were determined in absolute units (ms2), and as per Task Force recommendations [18] {, 
1996 #106}, HF and LF power were both transformed (log10) and normalized (%; 
LFnu=LF power/(total power-VLF power) x 100, and HFnu=HF power/(total power-VLF 
power) x 100).  HF power is considered an index of vagal HR modulation, and LF power 
is considered an index of primarily sympathetic modulation, with some contribution from 
the efferent vagus [18].  The LF/HF ratio has been proposed as a rough estimate of 
cardiac sympatho-vagal balance [18]. For all data sets, only stationary time series with 
≤5% arrhythmia or artefact were used for analyses. 
 
LBNP:  With subjects in the supine position, the lower body was encased in a custom 
built chamber that was sealed at the level of the iliac crest [19].  The chamber was 
attached to a vacuum source to effect reductions in pressure.  HR, BP, respiratory 
excursions and HRV were continuously recorded at baseline and during each 8-minute 
stage of LBNP (-10, -20, and -40 mmHg).  Each LBNP stage was followed by 5-minutes 
of recovery (i.e., no LBNP).  LBNP was terminated if SBP declined to <80mmHg, pallor 
was observed, and/or subjective feelings of nausea, dizziness and/or light-headedness 
were reported. 
 
Statistics:  All data sets were tested for non-normality, homogeneity of variance, and 
outliers. Consistent with previous literature [18], raw HRV data were non-normally 
distributed. Thus, both normalized and log10 converted LF and HF raw data were 
calculated.  At baseline, between-group differences were detected using one-way 
6 
 
analysis of variance (ANOVA), and when a significant main (fixed) effect was observed, 
within-group and between-group analyses of responses to LBNP, including change (∆) in 
measures compared to baseline, were determined using mixed model ANOVA, using 
GROUP as the between-group factor.  When significant within-group and between-group 
differences were detected, Bonferroni methods were used to determine where the 
significant differences existed.  When assumptions of sphericity were violated, the 
Greenhouse-Geisser correction was used.  Using pooled data, Pearson’s correlational 
analyses were used to determine significant linear independent associations between 
HRV indices and variables of interest.  Data were analyzed using packaged software 
(SPSS version 20; SPSS Inc., Chicago, IL).  All data are presented as the mean±SEM. 
A significance level of p<0.05 was used to detect the differences for statistical 
procedures.   
 
RESULTS 
Subject Characteristics:  Groups did not differ (p>0.05) in age, height, weight, or body 
composition (Table 1). Sedentary women were significantly less aerobically conditioned 
(p<0.001) compared with exercising women.  Serum measures of 17 β-estradiol (pmol/L) 
did not differ (p>0.05) between ovulatory groups. In contrast, 17 β-estradiol was lower 
(p<0.05) in ExFHA compared with ExOv only.  Progesterone was similar (p>0.05) 
between groups (1.8 ± 0.7 nmol/L; pooled mean).  Free T3 (pmol/L) was significantly 
lower (p<0.05) in ExFHA compared with ExOv and SedOv women. Testosterone and 
FAI did not differ (p>0.05) between groups.  SHBG was lower (p<0.05) in SedOv versus 
ExOv and ExFHA women.    
 
Blood Pressure and Heart Rate:  Baseline Values: Between groups, HR and SBP were 
lower (p<0.05) in ExFHA women than in SedOv and ExOv women, in whom HR and 
SBP did not differ (p>0.05; Table 2).  Baseline DBP was similar (p>0.05) between the 
groups.   
LBNP Responses: Within groups, graded LBNP elicited a significant increase 
(p<0.05) in HR, and a decrease (p<0.05) in SBP and DBP.  Between-groups, analyses 
showed that HR and SBP values during LBNP remained significantly lower (p<0.05) in 
ExFHA compared with SedOv and ExOv women.  DBP values during LBNP did not differ 
(p>0.05, main effect) between the groups.  No between-group differences for BP and HR 
values were detected during graded LBNP for SedOv and ExOv women (p>0.05).  Delta 
values (data not shown) for all HR and BP responses did not differ (p>0.05) between all 
groups.   
 
Heart Rate Variability: Baseline Values: Complete HRV data were unavailable in one 
SedOv woman whose study was terminated when presyncopal symptoms were evoked 
by -20 mmHg LBNP.  ExFHA women demonstrated higher (p<0.05; main effect) 
baseline HF (ms2), Total HRV, and HFlog10 compared with SedOv and ExOv women 
(Table 3).  LF/HF ratio trended lower (p=0.095) in ExFHA women than ovulatory women. 
In contrast, groups did not differ (p>0.05) with respect to baseline VLF (ms2), LF (ms2), 
LF/HF ratio, LFnu, HFnu, and LFlog10.  HRV did not differ (p>0.05) between ExOv and 
SedOv women.   
LBNP Responses:  Within-groups, LBNP elicited significant reductions in Total 
HRV (F(1.92, 82.66)=7.175, p=0.002; main effect), HFnu (F(2.31, 99.29)=46.54, 
p<0.001), and HFlog10 (F(1.63, 70.18)=72.411, p<0.001; Figure 1).  In contrast, LF/HF 
ratio (F(1.42, 61.07)=30.156, p<0.001), and LFnu (F(2.29, 102.92)=44.239, p<0.001) 
were increased by LBNP.  VLF (ms2), LF (ms2), and LFlog10 (ms2) were unaltered 
(p>0.05) by LBNP.  No LBNP x Group interactions (p>0.05) were detected.  Between-
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groups, ExFHA women demonstrated significantly higher Total HRV (p=0.001; main 
effect), HFnu (p<0.001; main effect) and HFlog10 (p<0.001; main effect) at each LBNP 
stage compared with SedOv and ExOv women.  Conversely, LF/HF ratio was 
significantly lower (p=0.023; main effect) at -20mmHg and -40mmHg in ExFHA versus 
SedOv women only.  HRV did not differ (p>0.05) between SedOv and ExOv women at 
any LBNP stage.  Delta HRV responses to LBNP did not differ (p>0.05) between the 
groups.   
 
Respiration Rate: Respiration rate did not differ (p>0.05; main effect) between groups 
at baseline (14.2±0.4 breaths/minute; overall baseline mean ±SEM), nor was it altered 
by LBNP (p>0.05, main effect). 
 
Correlates of HR and HRV:  Resting HR was positively associated with 17 β-estradiol 
(r=0.517, p=0.001) and T3 (r=0.611, p<0.001).  In contrast, baseline measures of LFlog10 
(r= -0.028 ), HFlog10 (r= -0.299) and Total HRV (r= -0.164) were not associated (p>0.05) 
with serum measures of 17 β-estradiol.  No resting measure for HRV correlated with T3 
(all p>0.05).      
 
 
DISCUSSION 
To our knowledge, this is the first study to evaluate autonomic heart rate modulation 
using frequency domain analysis of heart rate variability in estrogen deficient exercise 
trained premenopausal women with functional hypothalamic amenorrhea. We report that 
compared with age-matched eumenorrheic sedentary and exercise-trained estrogen 
replete women, exercise-trained estrogen deficient premenopausal women have lower 
heart rate both at rest and during orthostatic stress.  LBNP reflexively increased heart 
rate in all groups in association with lowered HF, unaltered LF and increased LF/HF 
ratio.  However, hypoestrogenic exercise trained premenopausal women demonstrated 
higher HF and Total power values at rest and during orthostatic stress compared with 
their exercise-trained and sedentary eumenorrheic peers.  LF/HF ratio was also 
significantly lower in amenorrheic than eumenorrheic sedentary women during LBNP. 
Collectively, these observations are consistent with the concept that otherwise healthy 
hypoestrogenic exercise-trained premenopausal women have augmented vagal HR 
modulation, resulting in greater total HRV spectral power.     
 
Estrogen and Autonomic HR Modulation  
Several lines of evidence support the concept that estrogen modulates HR and cardiac 
autonomic tone.  For example, premenopausal women demonstrate higher basal cardiac 
vagal tone compared with age-matched males [20,21] and postmenopausal women [21]. 
Estrogen therapy lowers resting HR in normotensive postmenopausal women [22], and 
increases vagal and/or decreases sympathetic HR modulation at rest in most [20,21] but 
not all [23] postmenopausal women.  The effects of fluctuating estrogen levels across 
menstrual cycle on HRV are less clear, likely in part due to differences in the timing of 
data collection across the cycle.  Notwithstanding, studies variably report greater [24,25] 
and unaltered [26] HRV during the follicular (increasing estrogen, low progesterone) 
versus the mid-luteal (high estrogen and progesterone) phase.  In animals, 17 β-
estradiol administration increases parasympathetic and decreases sympathetic 
modulation of HR in both male and ovariectomized rodents [27].  The expression of 
significant populations of both estrogen receptor-alpha and -beta on cell bodies, axons 
and terminals of autonomic regulatory nuclei throughout the neuraxis is thought to 
explain in part the autonomic effects of estrogen [28].   
8 
 
In contrast with the literature in postmenopausal women, we report that despite 
hypoestrogenemia, LF HRV did not differ between the three study groups, yet vagal 
modulation of HR was enhanced both at rest and during LBNP in ExFHA women. 
Further, LF/HF ratio was lower during -20 and -40mmHg LBNP in ExFHA versus 
sedentary eumenorrheic women, suggesting that their reflex sympathetic HR response 
to this stimulus may also be attenuated.  An alternate interpretation is that the 
parasympathetic response was reflected in both the numerator and denominator of this 
ratio.   It has been demonstrated that LF is not purely an index of cardiac sympathetic 
modulation, rather it is a marker of both sympathetic and vagal heart rate modulation, 
including modulation by the arterial baroreflex [29].  The supine position, as utilized in 
the current study, is also associated with greater vagal values compared with the seated 
or standing position [30]. Thus, it is possible that in the current study supine LF HRV, 
and indeed LF/HF, was primarily influenced by parasympathetic modulation.  Because 
of this complexity, HF rather than LF was our principal focus of investigation in 
this experiment. 
Collectively, low resting HR and augmented HRV in ExFHA women at rest and 
during LBNP suggests that these findings are not a direct consequence of estrogen 
deficiency.  In light of the etiology of FHA in physically active women, alternative factors 
contributing to the elevated parasympathetic modulation of HR in ExFHA may include 
energy deficiency (i.e., caloric deficit), aerobic exercise training, and low brain and 
circulating angiotensin II concentrations, all of which are independently associated with 
augmented vagal modulation of HR [9,10,31,32].  The possible contribution of these 
three factors to the observed enhanced HRV in ExFHA women are considered below. 
 
Energy Deficiency and HR Modulation  
Amenorrhea in weight-stable active women is causally linked to mild negative energy 
balance in association with increased energy expenditure that is frequently combined 
with subtle deficits in caloric intake [4].  In response to energy deficiency, circulating T3 
levels are decreased in ExFHA women [33].  In accordance with this, we report low T3 in 
ExFHA women compared with eumenorrheic women.  T3 is known to exert positive 
modulatory effects on HR by binding primarily to thyroid receptor-α expressed in the 
heart and the vasculature, eliciting genomic and non-genomic actions that influence 
gene transcription and peripheral hemodynamics [34].  As previously reported by our 
group [33], we observed a strong positive association between circulating levels of T3 
and HR.  In contrast, we did not observe a correlation between T3 and any index of 
HRV. This observation is perhaps not too surprising since the contemporary literature 
concerning thyroid hormones and heart rate variability has yet to achieve consensus.  
For example, the influence of the parasympathetic nervous system on HR is reported as 
being reduced in both hypo- and hyperthyroidism, with pharmacological restoration of 
euthyroid status eliciting increases in cardiac vagal tone [35,36].  Conversely, in both 
human and animal studies, low T3 elicited by caloric restriction alone has been 
correlated positively with HRV due to increased HF and/or decreased LF power [34]. 
 
Exercise Training and HR Modulation 
Aerobic conditioning in humans is associated with resting bradycardia and increased 
HRV with greater resting parasympathetic and less sympathetic efferent heart rate 
modulation [9,10].  Alterations in the intrinsic sino-atrial node pacemaker [37] and 
neurotransmission at the level of the nucleus tractus solitarius [38] have been implicated 
in these changes.  In the current study, we report similar cardio-respiratory fitness in our 
exercising groups yet lower HR and higher vagal modulation of HR both at rest and 
during LBNP in ExFHA versus ExOv women.  In active young women high-volume and -
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intensity exercise training elicits greater vagal modulation of HR at rest and during 
postural stress compared with women undertaking low-intensity and -volume exercise 
training [39], and high-intensity exercise training leads to greater cardiorespiratory 
fitness than moderate- or low-intensity exercise training [40]. With the two active groups 
having similar fitness, it is therefore unlikely that exercise training intensity per se can 
account for the augmented vagal modulation of HR in ExFHA women.  Interestingly, the 
present finding is consistent with reports of augmented cardiac vagal modulation of HR 
in aerobically trained ovariectomized versus intact rats [41,42], suggesting that 
hypoestrogenemia may modulate exercise-training induced effects on parasympathetic 
HR modulation.  Examination of such postulates awaits delineation. 
 
Angiotensin II and HR Modulation: Recently, our group reported that compared with 
estrogen replete ExOv women, ExFHA women demonstrate an absence of reflex 
activation of circulating renin and angiotensin II in response to orthostatic stress [5] 
{O'Donnell, 2015 #1343}.  Substantial evidence links the renin-angiotensin-aldosterone 
system and the sympathetic nervous system [32,43,44]. Interactions can occur at central 
sites, such as in the rostral ventrolateral medulla and hypothalamus, and at the 
sympathetic prejunctional angiotensin II type 1 receptor, which facilitates norepinephrine 
release from the sympathetic nerve terminal [32,43,44].  Blockade of the angiotensin II 
type 1 receptor decreases sympathetic modulation of HR in experimental heart failure 
[44] and administration of angiotensin converting enzyme inhibitors increases vagal 
modulation of HR in patients after acute myocardial infarction [43].  Thus, angiotensin II 
exerts both sympatho-stimulatory and vagal-inhibitory effects on HR modulation [32].  Of 
note, angiotensin II infusion has been reported to elicit sex-specific cardiac autonomic 
responses, with healthy young men exhibiting a shift toward sympathovagal imbalance 
due to withdrawal of parasympathetic activity, and healthy young women demonstrating 
unaltered sympathovagal balance [45].  Whether resistance to the vagolytic effects of 
angiotensin II infusion is diminished in functionally hypoestrogenemic women, is 
unknown.  However, our previous finding of significantly lower circulating angiotensin II 
concentrations at -20 and -40 mmHg in ExFHA (2.1±0.3 and 2.0±0.4 pmol/L, 
respectively) versus ExOv women (5.3±1.4 and 8.6±1.9 pmol/L, respectively) [5] 
suggests that low circulating angiotensin II in ExFHA women during orthostatic stress 
may contribute to their augmented cardiac parasympathetic tone during LBNP.   
 
Limitations:  Respiratory sinus arrhythmia, or the HF (vagal) component of HRV, is 
influenced by both the depth and frequency of respiration [46].  Despite having similar 
breathing frequencies (~14 breaths per minute) among our study groups, it is possible 
that women with ExFHA may have different tidal volumes, which were not recorded.   
Due to the low prevalence (~2-5%) [3] and the psychogenic- and/or weight loss-related 
origins of FHA in sedentary women [47], our investigations did not extend to the effects 
of premenopausal estrogen deficiency on HRV in such women. Therefore, our study 
findings are limited to the effects of estrogen deficiency combined with exercise training 
on HRV. 
 
Conclusion:  Estrogen is assumed to elicit cardioprotective effects on the autonomic 
nervous system, including elevated HRV in association with increased vagal and 
decreased sympathetic modulation of HR [21].   In contrast to this concept, we report 
that physically active estrogen deficient premenopausal women with FHA demonstrate 
elevated HRV as a consequence of increased vagal HR modulation both at rest and 
during graded orthostatic stress.  Further, HRV is elevated in ExFHA women above that 
observed in fitness-matched estrogen replete women.  While the influence of estrogen 
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deficiency per se on cardiac autonomic modulation in ExFHA women is unclear, these 
findings suggest complex interactions between competing factors may oppose the 
cardiac autonomic modulatory effects of estrogen deficiency. In light of the etiology of 
FHA in active women, such factors likely include low circulating levels of triiodothyronine, 
angiotensin II, and exercise training-estrogen interactions.     
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Table 1.  Demographic and anthropometric measures of the study groups. 
 
 SedOv ExOv ExFHA P value 
  n=17 n=17 n=11 (main effect) 
Age (years) 23.5 ± 0.6 23.5 ± 1.2 25.4 ± 1.1 0.312 
Height (m) 1.65 ± 1.5 1.66 ± 1.5 1.67 ± 1.5 0.400 
Weight (kg) 58.6 ± 1.5  58.0 ± 1.9 58.7 ± 2.3 0.953 
BMI (kg/m2) 21.7 ± 0.5 20.9 ± 0.5 20.8 ± 0.8 0.438 
Body fat (%) 28.7 ± 2.3 24.7 ± 2.0 21.8 ± 2.2 0.118 
Fat free mass (kg) 38.8 ± 1.4 42.0 ± 1.6 44.1 ± 1.3 0.092 
Estradiol (pmol/L) 130.9 ± 10.9 148.7 ± 19.2 87.8 ± 14.7* 0.007 
Progesterone (nmol/L) 1.7 ± 0.2 1.8 ± 0.2 1.7 ± 0.2 0.895 
T3 (pmol/L) 4.2 ± 0.2 4.3 ± 0.1 3.6 ± 0.6† <0.001 
Testosterone (nmol/L) 2.4 ± 0.2 2.1 ± 0.2 2.4 ± 0.2 0.371 
SHBG (nmol/L) 40.5 ± 2.7‡ 52.9 ± 1.9 51.6 ± 4.1 0.020 
FAI (au) 0.06 ± 0.02 0.05 ± 0.01 0.05 ± 0.01 0.137 
VO2 peak (mL/kg-1/min-1) 38.9 ± 0.8
‡ 46.6 ± 1.3 47.8 ± 2.0 <0.001 
Values are mean±SEM. 
BMI, body mass index; FAI, free androgen index; T3, triiodothyronine; VO2 peak, peak 
oxygen consumption. 
 
* ExFHA vs ExOv  
† ExFHA vs ExOv and SedOv 
‡ SedOv vs ExOv and ExFHA 
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Table 2.  Blood pressure and heart rate responses to graded LBNP. 
  HR SBP DBP MAP 
SedOv† 
    Ba 61 ± 2 102 ± 2 59 ± 1 74 ± 1 
-10 mmHg 61 ± 2 98 ± 2§ 55 ± 1§ 69 ± 1§ 
-20 mmHg 65 ± 3 96 ± 1§ 53 ± 1§ 67 ± 2§ 
-40 mmHg 80 ± 3§ 94 ± 2§ 51 ± 2§ 66 ± 2§ 
     ExOv† 
    Ba 57 ± 2 105 ± 2 61 ± 1 76 ± 1 
-10 mmHg 58 ± 2 102 ± 2§ 57 ± 2§ 72 ± 2§ 
-20 mmHg 62 ± 3§ 100 ± 2§ 54 ± 2§ 70 ± 2§ 
-40 mmHg 72 ± 3§ 98 ± 1§ 53 ± 2§ 68 ± 2§ 
     ExFHA† 
    Ba 47 ± 2* 94 ± 2* 58 ± 2 70 ± 2 
-10 mmHg 48 ± 2* 93 ± 2* 56 ± 2 68 ± 2 
-20 mmHg 49 ± 2* 92 ± 2* 53 ± 2§ 66 ± 2§ 
-40 mmHg 60 ± 2*§ 89 ± 2*§ 51 ± 2§ 64 ± 2§ 
Values are mean±SEM. 
 
Ba, baseline; DBP, diastolic BP; HR, heart rate; MAP, mean arterial BP; SBP, systolic 
BP. 
 
† LBNP main effect for HR, SBP, DBP and MAP within each group, p<0.001. 
* ExFHA versus SedOv and ExOv within condition, p<0.05. 
§ Significantly different from baseline within groups, p<0.05. 
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Table 3.  Baseline HRV for the study groups. 
 
  SedOv ExOv ExFHA P 
  n=17 n=17 n=12 
(main  
effect) 
Absolute (ms2)     
LF  686 ± 135 1024 ± 265 1023 ± 165 0.398 
HF  837 ± 122 948 ± 130 2364 ± 757* 0.012 
VLF  818 ± 115 1160 ± 179 1705 ± 549 0.114 
LF+HF 1524 ± 220 1971 ± 341 3386 ± 894** 0.034 
Total (LF+HF+VLF) 2347 ± 253 3137 ± 349 5092 ± 1310* 0.021 
LF/HF  0.9 ± 0.1 1.1 ± 0.2 0.6 ± .01 0.095 
     
Normalized (%)     
LF (LF/[LF+HF]*100) 44 ± 3 46 ± 5 34 ± 4 0.129 
HF (HF/[LF+HF]*100) 56 ± 3 54 ± 5 66 ± 4 0.129 
     
Transformed (log10)     
LF  2.7 ± 0.1 2.8 ± .01 2.9 ± 0.1 0.516 
HF  2.8 ± 0.1 2.9 ± 0.1 3.2 ± 0.1* 0.022 
 
Values are mean±SEM. 
 
* ExFHA vs SedOv and ExOv, p<0.05 
** ExFHA vs SedOv, p<0.05 
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 Figure 1. Chart showing frequency domain indices of heart rate variability (HRV) at 
baseline and during graded LBNP in SedOv (closed circles), ExOv (closed squares) and 
ExFHA (open triangles) women. HRV indices include : HF log10 (A), LFlog10 (B), Total 
HRV (C), and LF/HF (D).  
 
* ExFHA versus SedOv and ExOv, p<0.05 ; § ExFHA versus ExOv, p<0.05. L x G, LBNP 
x Group interaction. 
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